Augmedix Launches Industry's First Fully-Automated, GenAI-Powered, Medical Documentation Product for Emergency DepartmentsGlobeNewsWire • Wednesday
Augmedix Integrates with Andor Health to Revolutionize Ambient Clinical Documentation for Ambulatory Virtual CareGlobeNewsWire • 04/09/24
Augmedix and SADA Forge Partnership to Scale Ambient Documentation and Structured Data Products to Health Systems NationwideGlobeNewsWire • 04/04/24
Augmedix Delivers 45% Revenue Growth and Expanded Gross Margins for Fourth Quarter of 2023GlobeNewsWire • 03/18/24
Augmedix Announces New Positive Data and Enhancements to Its Ambient AI Product, Augmedix GoGlobeNewsWire • 03/12/24
Augmedix to Announce Fourth Quarter and Full Year 2023 Financial Results on March 18, 2024GlobeNewsWire • 03/08/24
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Augmedix, Inc. (NASDAQ: AUGX)PRNewsWire • 02/22/24
Augmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor ConferenceGlobeNewsWire • 01/16/24
Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring RevenueGlobeNewsWire • 01/05/24
Augmedix Partners with Google Cloud to Bring Medically-Tuned AI Technology to Ambient DocumentationPRNewsWire • 12/13/23
Augmedix Announces Closing of Public Offering of Common Stock, Including Additional Investments from HCA Healthcare and Redmile GroupGlobeNewsWire • 11/21/23
Augmedix Announces Pricing of Upsized Public Offering of 6,250,000 Shares of Common StockGlobeNewsWire • 11/16/23
Augmedix Announces Proposed Public Offering of 5,500,000 Shares of Common StockGlobeNewsWire • 11/15/23
How Much Upside is Left in Augmedix, Inc. (AUGX)? Wall Street Analysts Think 36.67%Zacks Investment Research • 11/10/23
Augmedix, Inc. (AUGX) is on the Move, Here's Why the Trend Could be SustainableZacks Investment Research • 11/10/23
Augmedix Delivers 50% Revenue Growth and Expanded Gross Margins for Third Quarter of 2023GlobeNewsWire • 11/06/23